go back

Maryland rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $562,341 · 10th–90th $537,032–$562,3410%50%10th$562,341Professionalmedian $562,341 · 10th–90th $562,341–$676,0830%50%90th$562,341$50.0K$100.0K$200.0K$500.0K$1.0M$2.0M$5.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$537,031.80 / $562,341.33 / $562,341.33
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $676,082.98
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $676,082.98
Kaiser Permanente
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$478,630.09 / $562,341.33 / $602,559.59
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $575,439.94
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$467,735.14 / $562,341.33 / $660,693.45
Wellpoint
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $741,310.24